AlzChem Group AG (ETR:ACT)
Germany · Delayed Price · Currency is EUR 165.50
+1.00 (0.61%)
Aug 17, 2026, 4:54 PM CET
AlzChem Group AG Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 578.46 | 562.12 | 554.23 | 540.65 | 542.22 | 422.29 |
Other Revenue | 15.35 | 12.94 | 9.21 | 5.14 | 7.31 | 7.11 |
| 593.8 | 575.05 | 563.44 | 545.79 | 549.53 | 429.41 | |
Revenue Growth | 5.50% | 2.06% | 3.23% | -0.68% | 27.97% | 11.22% |
Cost of Revenue | 204.09 | 199.05 | 214.97 | 241.72 | 279.26 | 171.1 |
Gross Profit | 389.71 | 376.01 | 348.47 | 304.07 | 270.27 | 258.3 |
Selling, General & Admin | 183.47 | 177.58 | 164.29 | 149.35 | 138.68 | 133.03 |
Other Operating Expenses | 85.18 | 81.94 | 82.92 | 75 | 76.87 | 63.97 |
Operating Expenses | 296.5 | 286.17 | 273.52 | 250.26 | 241.09 | 221.47 |
Operating Income | 93.21 | 89.84 | 74.95 | 53.81 | 29.17 | 36.84 |
Interest Expense | -2.08 | -1.88 | -2.66 | -4.36 | -1.64 | -1 |
Interest & Investment Income | 2.46 | 3.24 | 2.23 | 0.35 | 8.21 | 0.63 |
Currency Exchange Gain (Loss) | 0.03 | -3.26 | 0.82 | -1.64 | 0.1 | 0.03 |
Other Non Operating Income (Expenses) | - | - | - | - | 5.23 | - |
EBT Excluding Unusual Items | 93.62 | 87.94 | 75.34 | 48.16 | 41.08 | 36.5 |
Gain (Loss) on Sale of Investments | - | - | - | 0.03 | 0.21 | 0.02 |
Pretax Income | 93.62 | 87.94 | 75.34 | 48.19 | 41.28 | 36.51 |
Income Tax Expense | 25.67 | 24.31 | 21.1 | 13.4 | 11.06 | 8.75 |
Earnings From Continuing Operations | 67.94 | 63.63 | 54.25 | 34.79 | 30.22 | 27.76 |
Minority Interest in Earnings | -0.17 | -0.17 | -0.17 | -0.17 | -0.17 | -0.17 |
Net Income | 67.77 | 63.46 | 54.08 | 34.62 | 30.05 | 27.59 |
Net Income to Common | 67.77 | 63.46 | 54.08 | 34.62 | 30.05 | 27.59 |
Net Income Growth | 17.01% | 17.35% | 56.19% | 15.20% | 8.91% | 40.11% |
Shares Outstanding (Basic) | 10 | 10 | 10 | 10 | 10 | 10 |
Shares Outstanding (Diluted) | 10 | 10 | 10 | 10 | 10 | 10 |
Shares Change | -0.25% | -0.67% | 0.05% | 0.33% | -0.11% | -0.29% |
EPS (Basic) | 6.70 | 6.28 | 5.31 | 3.40 | 2.96 | 2.72 |
EPS (Diluted) | 6.70 | 6.28 | 5.31 | 3.40 | 2.96 | 2.72 |
EPS Growth | 17.30% | 18.14% | 56.12% | 14.82% | 9.03% | 40.52% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -22.08 | 39.22 | 62.05 | 52.11 | -33.31 | 14.48 |
Free Cash Flow Per Share | -2.18 | 3.88 | 6.10 | 5.13 | -3.29 | 1.43 |
Dividend Per Share | 2.100 | 2.100 | 1.800 | 1.200 | 1.050 | 1.000 |
Dividend Growth | 16.67% | 16.67% | 50.00% | 14.29% | 5.00% | 29.87% |
Gross Margin | 65.63% | 65.39% | 61.85% | 55.71% | 49.18% | 60.15% |
Operating Margin | 15.70% | 15.62% | 13.30% | 9.86% | 5.31% | 8.58% |
Profit Margin | 11.41% | 11.04% | 9.60% | 6.34% | 5.47% | 6.43% |
Free Cash Flow Margin | -3.72% | 6.82% | 11.01% | 9.55% | -6.06% | 3.37% |
EBITDA | 118.13 | 113.55 | 98.44 | 77.08 | 51.96 | 58.66 |
EBITDA Margin | 19.89% | 19.75% | 17.47% | 14.12% | 9.46% | 13.66% |
D&A For EBITDA | 24.92 | 23.71 | 23.49 | 23.26 | 22.79 | 21.83 |
EBIT | 93.21 | 89.84 | 74.95 | 53.81 | 29.17 | 36.84 |
EBIT Margin | 15.70% | 15.62% | 13.30% | 9.86% | 5.31% | 8.58% |
Effective Tax Rate | 27.42% | 27.64% | 28.00% | 27.80% | 26.79% | 23.96% |